全球睡眠呼吸中止設備市場規模（按診斷設備、治療設備、地區、範圍和預測）

睡眠呼吸中止症設備的市場規模與預測

預計睡眠呼吸中止症設備市場在 2023 年的價值將達到 58 億美元，到 2030 年將達到 80 億美元，在預測期內（2024-2030 年）的複合年增長率為 6.5%。

睡眠呼吸中止症設備的全球市場推動因素

睡眠呼吸中止症設備市場的市場推動因素可能受到多種因素的影響。

睡眠呼吸中止症盛行率不斷上升

一個重要因素是全球睡眠呼吸中止症的盛行率不斷上升。久坐的生活方式、肥胖、人口老化以及認識和診斷的提高等多種因素促使尋求治療的患者數量增加。

技術開發

技術進步使得更舒適、更有效、更容易使用的睡眠呼吸中止症治療設備得以開發。持續性呼吸道正壓通氣 (CPAP) 設備、口腔器具和其他設備的設計、功能和連接性的改進正在改善治療效果和患者的依從性。

提高知名度和認可度

公眾和醫療保健專業人員對未治療的睡眠呼吸中止症相關的健康風險的認識不斷提高，促使診斷率上升。隨著越來越多的人被診斷出患有睡眠呼吸暫停，對有效治療工具的需求也隨之增加。

增加醫療支出

先進睡眠呼吸中止症設備的使用受到醫療保健支出的增加的推動，尤其是在已開發國家。市場成長也將受到睡眠呼吸中止症治療的保險覆蓋範圍和報銷指南的影響。

家庭醫療保健的趨勢：

在家中管理睡眠呼吸中止症等慢性疾病的趨勢推動了對便攜式、易於使用的設備的需求。患者更喜歡微創治療，因為這樣他們就可以控制疾病而不干擾他們的日常生活。

夥伴關係與合作關係

尖端睡眠呼吸中止症設備的開發由主要行業參與者、醫療保健提供者和研究機構之間的合作推動。這些合作透過促進資訊、資源和技術的共享促進了市場擴張。

政府計畫

睡眠呼吸中止症市場可能會受益於政府針對睡眠障礙的計劃、支持宣傳活動以及增強醫療服務的機會。價格低廉的設備研發和銷售將得到政策的支持，這也將有助於市場的擴大。

老年人口增加

肥胖和肌肉力量下降使老年人更容易患睡眠呼吸中止症。隨著老年人口的增加，對診斷和治療睡眠呼吸中止症的工具的需求預計會增加。

限制全球睡眠呼吸中止設備市場的因素

有幾個因素可能會對睡眠呼吸中止症設備市場造成限製或課題。

成本高

許多睡眠呼吸中止症治療的費用可能促使無法獲得治療，特別是對於醫療保健較差或缺乏足夠保險的地區的人們。

有限補償政策

在某些地區，當保險無法完全承擔睡眠呼吸中止症設備的費用時，患者可能會面臨經濟障礙。

認知度低

患者和醫療保健專業人員通常缺乏有關睡眠呼吸中止問題及其可用治療方法的瞭解，這可能促使誤診和治療不足。

副作用

有些患者在使用睡眠呼吸中止症設備時可能會感到不適或副作用。這些症狀包括面罩過敏和難以適應持續性呼吸道正壓通氣 (CPAP) 治療。

合規性問題

由於各種原因，包括不適、不便以及難以適應在睡覺時佩戴設備，一些患者可能難以堅持他們的治療計劃，尤其是 CPAP 治療。

替代療法

儘管外科手術和口腔器具可能會與睡眠呼吸中止症設備市場競爭，但有些人可能更喜歡或選擇這些替代方法來治療睡眠呼吸中止症。

監理障礙

嚴格的醫療器材監管法律可能會延長睡眠呼吸中止症治療的開發和商業化所需的時間，並可能阻礙創新和市場發展。

限制獲得醫療保健的機會

在缺乏專業睡眠診所和醫療保健服務的地區，患者可能難以及時得到睡眠呼吸中止症的診斷和治療。

目錄

第 1 章簡介

• 市場定義
• 市場區隔
• 研究方法

第 2 章執行摘要

• 主要發現 市場概況 市集亮點

第3章 市場概覽

• 市場規模與成長潛力
• 市場趨勢
• 市場推動因素
• 市場限制
• 市場機會
• 波特五力分析

第 4 章睡眠呼吸中止症設備市場（依診斷設備劃分）

• 多導睡眠圖 (PSG) 設備
• 居家睡眠測試 (HST) 設備

第 5 章睡眠呼吸中止症治療設備市場（按治療設備）

• 氣道正壓通氣 (PAP) 裝置
• 口腔器具
• 嵌入式設備

第6章 區域分析

• 北美洲
• 美國
• 加拿大
• 墨西哥
• 歐洲
• 英國
• 德國
• 法國
• 義大利 亞太地區
• 中國
• 日本
• 印度
• 澳大利亞
• 拉丁美洲
• 巴西
• 阿根廷
• 智利
• 中東和非洲
• 南非
• 沙烏地阿拉伯
• 阿拉伯聯合大公國

第 7 章 市場動態

• 市場推動因素
• 市場限制
• 市場機會
• COVID-19 市場影響

第 8 章 競爭格局

• 大型公司
• 市佔率分析

第9章 公司簡介

• ResMed Inc.
• Philips Respironics（a division of Royal Philips）
• Fisher & Paykel Healthcare
• SomnoMed
• BMC Medical Co.Ltd.
• Drive DeVilbiss Healthcare
• Braebon Medical Corporation
• Compumedics Limited
• Whole You Inc.（a subsidiary of Mitsui Chemicals, Inc.）
• Fisher Wallace

第10章 市場展望及機會

• 新興技術
• 未來市場趨勢
• 投資機會

第 11 章附錄

• 縮寫列表
• 來源與參考文獻

Sleep Apnea Devices Market Size And Forecast

Sleep Apnea Devices Market size was valued at USD 5.8 billion in 2023 and is projected to reach USD 8.0 billion by 2030 , growing at a CAGR of 6.5% during the forecast period 2024-2030. Global Sleep Apnea Devices Market Drivers The market drivers for the Sleep Apnea Devices Market can be influenced by various factors. These may include:

Growing Prevalence of Sleep Apnea

One important contributing factor is the increasing incidence of sleep apnea worldwide. The number of patients seeking therapy is rising due to a number of factors including sedentary lifestyles, obesity, aging populations, and improved awareness and diagnosis.

Technological Developments

The creation of more cozy, effective, and user-friendly sleep apnea equipment is the result of technological advancements. The design, functionality, and connection of continuous positive airway pressure (CPAP) machines, oral appliances, and other devices have improved, improving treatment outcomes and patient compliance.

Increasing Recognition and Recognition Rates

Higher rates of diagnosis have resulted from increased knowledge of the health dangers associated with untreated sleep apnea among both the general public and healthcare professionals. There is an increasing need for efficient treatment tools as more people receive sleep apnea diagnoses.

Growing Healthcare Expenditure

The use of sophisticated sleep apnea equipment is encouraged by rising healthcare spending, especially in industrialized nations. The market's growth is also influenced by insurance coverage and reimbursement guidelines for sleep apnea treatments.

Trend toward Home-based Care:

The need for portable, user-friendly equipment is being driven by the trend toward managing chronic illnesses, such as sleep apnea, at home. Patients like minimally invasive therapies that enable them to control their illness without interfering with their regular routines.

Partnerships and Collaborations

The creation of cutting-edge sleep apnea equipment is facilitated by partnerships and collaborations amongst major industry participants, healthcare providers, and research institutes. These collaborations promote market expansion by facilitating the sharing of information, resources, and technology.

Government programs

The market for sleep apnea devices may benefit from government programs that target sleep disorders, support awareness campaigns, and enhance access to healthcare services. The development and marketing of inexpensive devices are aided by policies, which also contribute to market expansion.

Growing Senior Population

Obesity and a loss of muscle tone make the elderly population more prone to sleep apnea. The need for tools to diagnose and treat sleep apnea is predicted to increase as the number of elderly people increases..

Global Sleep Apnea Devices Market Restraints

Several factors can act as restraints or challenges for the Sleep Apnea Devices Market. These may include:

Expensive Cost

A lot of sleep apnea devices can be pricey, which may prevent patients from getting them, particularly in areas with little access to healthcare or for those without sufficient insurance.

Limited Reimbursement Policies

Patients seeking treatment may face financial obstacles if their insurance does not sufficiently cover the cost of sleep apnea devices in specific areas.

Low Awareness

Patients and medical professionals may misdiagnose or undertreat sleep apnea as a result of a lack of knowledge regarding the problem and the available treatments.

Adverse Effects

When utilizing some sleep apnea devices, some patients may have discomfort or side effects. These include irritability from masks or trouble adjusting to continuous positive airway pressure (CPAP) therapy.

Problems with Compliance

Some patients may find it difficult to adhere to treatment plans, especially when it comes to CPAP therapy, for a variety of reasons, including discomfort, inconvenience, or trouble getting used to wearing the device while they sleep.

Alternative Therapies

While surgical procedures and oral appliances can compete with the market for sleep apnea devices, some individuals may prefer or choose these alternative approaches to treating their sleep apnea.

Regulatory Obstacles

Tight laws governing medical devices could lengthen the time it takes to develop and commercialize sleep apnea solutions, thereby impeding innovation and market expansion.

Restricted Access to Healthcare

Patients may encounter difficulties receiving a prompt diagnosis and treatment for sleep apnea in areas with limited access to specialized sleep clinics or healthcare services, which may affect the market demand for sleep apnea devices..

Global Sleep Apnea Devices Market Segmentation Analysis

The Global Sleep Apnea Devices Market is Segmented on the basis of By Diagnostic Devices, By Therapeutic Devices, and Geography.

By Diagnostic Devices

Polysomnography (PSG) devices

Devices that use polysomnography (PSG) are the gold standard for identifying sleep apnea. PSG tests entail spending the night in a sleep lab under continuous physiological monitoring.

Devices for home sleep testing (HST):

An easier and more affordable way to diagnose sleep apnea is with a HST device. They are usually used at home and are designed to monitor specific physiological functions..

By Therapeutic Devices

Positive Airway Pressure (PAP) devices

The most often used kind of treatment for sleep apnea is the use of PAP devices. They function by maintaining the airway open while you sleep by applying pressured air. Continuous positive airway pressure (CPAP), bilevel positive airway pressure (BiPAP), and auto-titrating positive airway pressure (APAP) are the three primary categories of PAP devices.

Oral Appliances

To help maintain the airway open while you sleep, oral appliances are a sort of mouthpiece. Although they are usually not as effective as PAP devices, they could be a suitable substitute for those who are unable to undergo PAP therapy.

Implantable Devices

Currently in development, implantable devices represent a novel approach to treating sleep apnea. The way these gadgets function is by stimulating the nerves that govern the tongue and throat muscles.

By Geography

North America:

Market conditions and demand in the United States, Canada, and Mexico.

Europe:

Analysis of the Sleep Apnea Devices Market in European countries.

Asia-Pacific:

Focusing on countries like China, India, Japan, South Korea, and others.

Middle East and Africa:

Examining market dynamics in the Middle East and African regions.

Latin America:

Covering market trends and developments in countries across Latin America.

Key Players

The major players in the Sleep Apnea Devices Market are:

ResMed Inc.

Philips Respironics (a division of Royal Philips)

Fisher & Paykel Healthcare

SomnoMed

BMC Medical Co.Ltd.

Drive DeVilbiss Healthcare

Braebon Medical Corporation

Compumedics Limited

Whole You Inc. (a subsidiary of Mitsui Chemicals.Inc.)

Fisher Wallace

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Sleep Apnea Devices Market, By Diagnostic Devices

• Polysomnography (PSG) devices
• Devices for home sleep testing (HST)

5. Sleep Apnea Devices Market, By Therapeutic Devices

• Positive Airway Pressure (PAP) devices
• Oral Appliances
• Implantable Devices

6. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

7. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

8. Competitive Landscape

• Key Players
• Market Share Analysis

9. Company Profiles

• ResMed Inc.
• Philips Respironics (a division of Royal Philips)
• Fisher & Paykel Healthcare
• SomnoMed
• BMC Medical Co.Ltd.
• Drive DeVilbiss Healthcare
• Braebon Medical Corporation
• Compumedics Limited
• Whole You Inc. (a subsidiary of Mitsui Chemicals, Inc.)
• Fisher Wallace

10. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

11. Appendix

• List of Abbreviations
• Sources and References